A South Korean medical device maker has asked a Massachusetts federal judge to deny Insulet’s request for $30 million in attorney fees. This follows a $60 million trade secrets judgment against Insulet. The company seeking relief described the fee demand as “exorbitant,” criticizing Insulet for “consistently over-lawyered disputes.” Legal professionals may view this as a significant moment in the ongoing discourse over attorney fee awards in trade secret litigations.
For further details on the case and statements from the involved parties, refer to the extensive report by Law360.